Biotech by days to cover

Short interest at FINRA's latest settlement date divided by FINRA's average daily volume: the days of normal trading it would take short sellers to buy back. No volume, no figure.

Qiagen has the lowest figure of the 24 biotech ranked by days to cover, at 0.7, followed by Moderna (1.8) and BioNTech (2.2). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report.

Key facts

Companies ranked
24
Lowest
Qiagen0.7
Median
6.4
Combined market value
$849.5B
Countries
5

Market values as of .

Biotech by days to cover
#CompanyDays to cover ↑Market capPriceToday1 yearPrice, 30 daysCountry
1QiagenQGEN · Health Care0.7$10.3B$49.71 0.09% down 12% up Netherlands
2ModernaMRNA · Health Care1.8$84B$207.57 0.37% up 755% up United States
3BioNTechBNTX · Health Care2.2$21.1B$84.97 0.13% up 16% down Germany
4Bio-TechneTECH · Health Care2.7$11.4B$72.73 0.14% up 26% up United States
5Gilead SciencesGILD · Health Care3.2$210.6B$169.79 0.28% down 33% up United States
6argenxARGX · Health Care3.4$60.6B$963.03 1.64% up 4% up Belgium
7BiogenBIIB · Health Care4.0$37.1B$251.00 0.08% up 49% up United States
8Twist BioscienceTWST · Health Care4.4$8.1B$118.29 5.62% up 340% up United States
9RepligenRGEN · Health Care4.9$11.1B$173.15 6.76% up 5% up United States
10AmgenAMGN · Health Care5.0$244.8B$452.48 1.19% down 34% up United States
11Neurocrine BiosciencesNBIX · Health Care5.4$16.6B$164.01 1.15% down 20% up United States
12Adaptive BiotechnologiesADPT · Health Care6.1$4.7B$29.03 1.90% up 88% up United States
13VaxcytePCVX · Health Care6.7$9.4B$59.30 0.17% down 22% up United States
14Halozyme TherapeuticsHALO · Health Care6.8$11.1B$97.17 1.25% up 37% up United States
15Revolution MedicinesRVMD · Health Care7.8$35B$162.04 0.40% down 131% up United States
16Kodiak SciencesKOD · Health Care9.3$6.5B$99.00 2.27% up 396% up United States
17Kymera TherapeuticsKYMR · Health Care10.5$10.6B$123.65 1.75% up 87% up United States
18ImmunityBioIBRX · Health Care10.8$7B$6.54 4.39% up 193% up United States
19CG OncologyCGON · Health Care11.0$6.9B$77.45 1.89% down 85% up United States
20ExelixisEXEL · Health Care11.7$16.9B$69.21 1.04% up 63% up United States
21Krystal BiotechKRYS · Health Care12.2$9.2B$309.08 3.53% up 46% up United States
22CRISPR TherapeuticsCRSP · Health Care13.1$4.1B$42.12 4.91% up 21% down Switzerland
23Scholar Rock HoldingSRRK · Health Care13.6$5.8B$47.75 5.92% up 14% up United States
24ImmunovantIMVT · Health Care15.3$7B$33.74 1.60% up 43% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. Days to cover is short interest divided by FINRA's average daily volume for the period, worked out here: FINRA's own printed figure is floored at 1 and capped at 999.99, so it is not used. A company with no average volume reported has no days to cover and is not ranked.

Questions and answers

Which biotech have the lowest days to cover?

Qiagen (0.7), Moderna (1.8) and BioNTech (2.2) have the lowest days to cover of the 24 biotech ranked here as of the 30 Oct 2026 settlement date.

How many biotech are in this ranking?

24 are ranked by days to cover.

What are these biotech worth together?

The 24 biotech ranked by days to cover have a combined market value of $849.5B as of the 30 Oct 2026 settlement date.

What does ranking by days to cover measure?

Short interest at FINRA's latest settlement date divided by FINRA's average daily volume: the days of normal trading it would take short sellers to buy back. No volume, no figure.

Cite this page

Funkfolio, “Biotech by days to cover”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=days-to-cover

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.